Thrombotic microangiopathy: Difference between revisions
From IDWiki
(Created page with "* Thrombotic thrombocytopenia purpura * Hemolytic-uremic syndrome * Atypical hemolytic-uremic syndrome Category:Hematology Category:Thrombosis") |
No edit summary |
||
| Line 1: | Line 1: | ||
*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction |
|||
| ⚫ | |||
*Primary |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
**[[HELLP syndrome]] |
|||
*Associated with coexisting condition |
|||
**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]] |
|||
**Drugs, including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition) |
|||
**[[Sepsis]] |
|||
**[[DIC]] |
|||
**[[Malignancy]] |
|||
**[[HIV]] |
|||
[[Category:Hematology]] |
[[Category:Hematology]] |
||
Revision as of 11:45, 15 August 2020
- Syndrome of microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis leading to organ dysfunction
- Primary
- Associated with coexisting condition
- Autoimmune disease, including systemic lupus erythematosus or antiphospholid antibody syndrome
- Drugs, including quinine, ticlopidine, and chemotherapy (mitomycin, gemcitabine, cyclosporine, and tacrolimus, though it may also be caused by the underlying condition)
- Sepsis
- DIC
- Malignancy
- HIV
